The Christie is developing a proton therapy centre that should treat its first patient in 2018. This talk will examine the scientific rationale for proton therapy as well as outlining the key considerations in the development of a national proton therapy service.
Over 100,000 patients have been treated with proton therapy worldwide but apart from a low energy eye service at Clatterbridge Cancer Centre patients have had to travel abroad for therapy. Currently the NHS sends patients to Europe and the US and decisions about access for proton therapy are often high profile and controversial.
This talk will examine how to develop the best proton therapy to meet the clinical need and repatriate the patients currently having to travel abroad for care. It will also examine developments of proton therapy worldwide and look at the future of proton therapy in the context of modern radiotherapy.
Talks start at 18.30 with sandwiches and refreshments available from 18.00. All are welcome and all our talks are free to attend.